|
|
||||||||
1 Center for Biomedical Engineering and 2 Division of Cardiology, University of Kentucky, Lexington, Kentucky 40506
| |
ABSTRACT |
|---|
|
|
|---|
Periods of reentrant activation and effective refractory periods are correlated with dominant frequency or reciprocal of cycle periods during ventricular fibrillation (VF). In the present study, we used an analysis technique based on Wigner transforms to quantify time-varying dominant frequencies in electrocardiograms (ECGs) during VF. We estimated dominant frequencies within orthogonal ECGs recorded in 10 dogs during trials of 10 s of VF and in 9 dogs during trials of 30 s of VF. In four additional dogs, we compared dominant frequencies during 10 s of VF before and after administration of amiodarone. Our results showed the following. 1) There was substantial frequency variation or modulation within the ECGs during 10 and 30 s of VF, the average variation being ±15% from the mean frequency. Amiodarone decreased mean frequencies (P < 0.05) as expected; however, amiodarone also decreased the variation in frequencies (P < 0.05). 2) During 30 s of VF, the dominant frequencies increased continuously from 7.3 to 8.1 Hz (P < 0.05). The increase in frequency was almost linear with a rate of 0.022 Hz/s (r2 = 0.93, P < 0.0005). 3) Modulation of frequencies during the first and the last one-half of 30 s of VF was not different. Average (in time) mean frequencies and modulation of frequencies were similar in all three ECGs. 4) Although the averages were similar, during any VF episode, dominant frequencies in ECGs recorded from different locations on the body surface were similar to each other at some times and markedly different from each other at other times. We conclude that during VF, 1) frequencies in ECGs vary considerably and continuously, and amiodarone decreases this variation; 2) mean frequencies increase linearly during first 30 s; 3) the variability in frequency does not change during 30 s; and 4) at any given time, the frequencies within spatially different body surface ECGs can be either similar or markedly different.
time-frequency analysis; refractory periods; arrhythmia; nonstationary; amiodarone; restitution
| |
INTRODUCTION |
|---|
|
|
|---|
A DOMINANT RHYTHM IS OBSERVED in electrocardiograms (ECGs) during ventricular fibrillation (VF). Cycle periods and amplitudes of the dominant rhythm, however, vary with time. Mechanisms of VF, hypothesized by other investigators (11, 12, 28), propose that nonstationary activation within the myocardium produces cycle period changes or frequency modulation. Recently, experimental data have shown that periods of reentrant activation during VF, mapped epicardially with the use of optical techniques, correlate with the dominant frequency within ECG (18). Results of this (18) and another study (29) show that drugs that change cellular conduction and repolarization properties change the periods of reentrant activation and, therefore, dominant frequencies within ECG. A correlation between local cycle periods measured during atrial fibrillation (AF), VF, and effective refractory periods has also been observed in several studies (16, 21, 22, 30). Collectively, results of these studies suggest that assessment of changes in dominant frequencies, or their reciprocal cycle periods, as VF evolves may provide an assessment of temporal changes in the properties of cellular substrate during VF. Assessment of temporal changes in cycle periods obtained from spatially different recordings, such as from body surface or epicardium, may be used to investigate spatio-temporal variation in these properties such as spatio-temporal dispersion of refractoriness (16). The generally recognized role of spatio-temporal variation in properties of cellular conduction and refractoriness in genesis of VF is further supported by the results of two recent studies (4, 23).
Our objective in the present study was to develop an analysis technique that provides assessment of time-varying changes in dominant frequencies during VF. The technique for assessment of changes in dominant frequencies does not require an often difficult process of detection of activation times. We demonstrate the application of the technique with the use of three orthogonal body surface ECGs. The technique can be easily applied, however, to recordings from multiple sites, from either the body surface, the epicardium, or the endocardium, and used to construct spatio-temporal cycle period maps. As discussed above, experimental evidence shows that dominant frequencies contain information about important physiological processes. Time-varying assessment of dominant frequencies, obtained from different spatial locations, can therefore be used to study dynamic spatio-temporal variation in these physiological processes.
| |
METHODS |
|---|
|
|
|---|
Data collection. Data were collected from 19 adult mongrel dogs of either sex weighing between 24 and 31 kg. All studies were approved by the Institutional Animal Care and Use Committee at the University of Kentucky. Anesthesia was induced with the use of Pentothal Sodium (25 mg/kg iv) and maintained with isoflurane (0.5/l vol%). Animals were intubated and ventilated. Normal blood gas and electrolyte levels were maintained. A defibrillation catheter (Endotak, CPI) was placed from the right jugular vein at the right ventricular apex. Defibrillation shocks were delivered between the apical coil electrode and a 14-cm2 patch electrode (L67, CPI) placed subcutaneously on the left side of the thorax over the apical impulse.
We recorded orthogonal ECGs in directions of X (sagittal), Y (transverse), and Z (longitudinal) (20). ECGs were band-pass filtered (0.5-400 Hz) and digitized online at the rate of 2,000 samples/s. Induction of VF was achieved with a 5-V AC shock (60 Hz). VF was permitted to continue for 10 s (10 dogs) and 30 s (9 dogs), at the end of which a defibrillation shock was delivered. Data were collected during 427 trials of 10 s of VF and during 335 trials of 30 s of VF. In four additional animals, data were collected during VF (10-30 s), before (43 trials) and after (36 trials) administration of amiodarone (100 mg iv). After administration of amiodarone, we waited ~25 min before conducting the next VF trial. At least 5-10 min were allowed between trials to resolve ischemic and ionic changes. Additional details of the experimental procedures are reported elsewhere (25, 26). To avoid the effects of transients and of the induction shock (7), data from the first 2 s of VF were not used for analysis. Figure 1 shows an example of the last 8 s of ECGs recorded during one 10-s trial. The rapid and large change in voltage observed at the end of 8 s is due to the defibrillation shock and was excluded from further analysis.
|
Assessment of frequency modulation.
We used the smoothed pseudo-Wigner distributions (SPWD) to estimate
dominant frequencies as VF progressed. As shown by Pola et al.
(27), compared with short-time Fourier transforms and parametric (autoregressive) approaches, the SPWD has excellent time
resolution and good frequency resolution at the expense of having
artifactual cross terms in the spectra. The ECGs recorded in dogs
during VF are primarily monocomponent within a frequency region of
~5-15 Hz (1-3, 5, 6,
8, 9, 13). Therefore, problems
associated with cross terms were not likely to affect the estimates of
dominant frequencies, and we could take advantage of the good time and
frequency localization permitted by the SPWD. The discrete SPWD is
given by (17)
|
k = 0.04 s]. The frequency F(k) of the maximum of the SPWD surface within
limits flow (fl), fhigh (fh) was
used to estimate instantaneous dominant frequency: F(k) = fm, where
fm is such that
|
9t +
sin2
0.8t). Such signal may be produced, for example, by a
rotating spiral with a circular core movement, as in the simulation
results in previous studies (11, 28). The
carrier frequency was selected as 9 Hz so as to be similar to the
average dominant frequency during VF in some dogs, and the modulating
frequency was selected to be 0.8 Hz, which gave a velocity ratio
between the two frequencies (analogous to the ratio between spiral
rotation and the core velocity) to be comparable with those reported by
Gray et al. (11, 12). The scaling factor
was selected to produce a maximum (max) change in frequency of 1.5 Hz.
A sinusoidal amplitude modulation function a(t)
was used to change the amplitude of the frequency-modulated signal, as
changes in amplitude in ECGs are also observed during VF. Figure
2A shows the changes in cycle periods and amplitudes in
5 s of simulated signal, x(t). Figure 2,
B and C, shows the time-frequency surface
estimated by the SPWD and the contour plot of the time-frequency
surface. The estimated dominant frequency, F(k)
(thick line going through the contours in Fig. 2C), shows that, as expected, the instantaneous frequency within series
x(t) oscillated between 10.5 and 7.5 Hz, around a
mean of 9 Hz.
|
| |
RESULTS |
|---|
|
|
|---|
A sample of ECG recorded during a 10-s trial in one dog (Fig.
3A) shows that during the last
8 s of VF, the amplitudes and cycle periods change considerably as
VF evolves. The time-frequency surface and the contour plots computed
from this ECG (Fig. 3, B and C) show how the SPWD
can be used to track changes in dominant frequency. The dominant
frequency is shown as a thick solid line overlaid on the contours in
Fig. 3C. To show changes in dominant frequency in detail
without the presence of other contours, the dominant frequencies are
plotted in Fig. 3D. Figure 3D shows that in this
trial of VF, the dominant frequency changed from 7 to ~11 Hz, around
a mean value of ~9 Hz. A gradual trend toward increasing mean
frequency is also evident in Fig. 3D.
|
Figure 4A shows the
average maximum, minimum, and mean dominant frequencies from 10 dogs
within one ECG (X) recorded during 10-s VF trials. The
maximum, minimum, and mean frequencies from all trials within each
animal were averaged to obtain one estimate of maximum, minimum, and
mean frequencies per animal. Variability in these frequencies within
each animal are shown in Fig. 4A as the standard deviation
plotted on the top of the average maximum, mean, and minimum
frequencies for each animal. Figure 4A shows that during
10 s of VF, the difference between slow and fast periods was as
large as 40-50% (for example, in a dog, a change from a minimum
of 7 to a maximum of 10.5 Hz). The standard deviations in Fig.
4A also show that although the mean frequencies during multiple trials within each animal were fairly similar (small standard
deviations in the middle, note different scale), there was
considerable variation in maximum and minimum dominant frequencies during VF (top and bottom panels). Figure
4B shows the average change in dominant frequencies
expressed as percent change from mean dominant frequency for 10 dogs.
Two standard deviations of the dominant frequency estimates
F(k) (computed over the entire 8 s) were
averaged within each animal to obtain an estimate of average variation
in frequencies. Figure 4B shows that for the 10 dogs,
average change in dominant frequency was considerable, between ±12 and
18%. Similar changes in dominant frequencies were observed for the
other two ECGs and also during 30 s of VF. To determine how the
frequencies were distributed above and below the mean frequency, we
estimated probability distribution functions with the use of smoothed
histograms. Shown in Fig. 5 are the
average probability distributions for all three ECGs from one dog
during 10-s VF trials. Figure 5 shows that the frequencies were
distributed symmetrically above and below the mean frequency in a shape
almost like a normal distribution.
|
|
Although the frequency distribution was similar for all three ECGs,
within any time interval during a VF episode, the dominant frequencies
within the three spatially different ECGs were not always similar. We
quantified the differences in dominant frequencies between the ECGs as
the square root of the squares of the differences between frequencies
from different ECGs, i.e., for ECGs X and Y
|
|
Figure 7 shows the average dominant
frequencies during 30 s of VF from nine animals. Figure
7A shows the dominant frequencies in three ECGs during the
last 28 s of the 30-s VF trials. In Fig. 7B,
corresponding to panels in Fig. 7A, are shown probability of
error values (i.e., the P value) for comparisons between
instantaneous frequencies and the "time-averaged initial frequency"
from the first 8 s of VF. Dominant frequencies for the first
8 s were averaged to obtain one initial frequency in each of the
335 trials; subsequent estimates of frequency
F(k) at each time step k in each trial were compared with the initial frequency with the use of one-way analysis of variance. Figure 7B shows that after ~11 s
from onset of VF, the increase in frequencies seen in Fig.
7A was significant (P < 0.05). A regression
analysis on these frequencies showed average slopes (and standard
deviations) to be 0.021 (0.014), 0.022 (0.016), and 0.021 (0.016) Hz/s
and the r2 values (all significant at
P < 0.0005) to be 0.92, 0.93, and 0.93 for the three
ECGs.
|
To validate the observed increase in frequencies during 30 s of VF, calculated by the use of nonstationary SPWD analysis in our study, we computed frequencies from these ECGs by using Fourier analysis (6, 8, 9, 30). We computed the dominant frequencies from blocks of 4 s of ECGs with the use of the Fourier transform, a stationary analysis technique used previously by others (6, 8, 9, 30). We computed dominant frequencies starting at 2, 10, and 26 s from the onset of VF. Comparison of frequencies, in three ECGs in all trials, computed at 10 and 26 s with those computed from the initial VF (starting at 2 s) showed a significant increase from 2 to 10 and 26 s (P < 0.02 and < 0.001). The magnitude of increases in frequencies at these two times were consistent with those shown in Fig. 7.
We explored whether the distribution of frequencies (above and below
the mean) changed with increasing duration of VF. First, we subtracted
the linear trend, estimated with the use of a linear regression, from
frequencies estimated from each trial. After removing the trend, we
estimated probability distribution with the use of smoothed histograms
from the first and the last 14 s of VF. Figure
8 shows the average probability
distributions of frequencies in the three ECGs in one dog. Because the
nonstationary mean frequency was removed before estimation of the
distributions, the distributions in Fig. 8 are centered at 0 Hz. Figure
8 shows that during the last part of the 30-s VF trial (dashed curves), the variation in frequencies above and below the mean frequency was
very similar qualitatively and quantitatively with that observed during
the first part of VF (solid curves).
|
To verify that expected alteration in cellular repolarization properties related changes in cycle periods can be estimated by using our technique, we compared dominant frequencies between VF trials before and after administration of amiodarone in four dogs. Results of 79 trials in these animals showed that during 10 s of VF, in all three ECGs, the dominant frequencies decreased from means of 6.5, 7.4, and 7.0 to 6.1, 6.4, and 6.3 Hz, respectively, after amiodarone (P < 0.005). Furthermore, the variations in dominant frequencies (i.e., 2 times the standard deviation) also decreased from 1.18, 1.38, and 1.19 to 0.98, 1.11, and 1.02 Hz, respectively. All differences were significant at a level of P < 0.02.
| |
DISCUSSION |
|---|
|
|
|---|
Time-frequency analysis has been used previously by other investigators (1, 2) to assess changes in the dominant frequency during VF. In these studies, assessment of dominant frequencies was made over a longer time scale relative to our study and with time resolution in tens of seconds or more. The focus of these earlier studies was on characterization of changes in dominant frequencies as a function of prolonged duration of VF (300 s or more) to predict duration of VF (1, 2) or to study effects of ischemia or anti-arrhythmic drugs on average dominant rhythm (8, 9). Assessment of dominant frequencies with the use of time-frequency analysis over shorter time scales of 10-30 s, with the finer time resolution that we used (40 ms), has not been previously reported. Investigation of the dynamics of activation pattern and cellular properties over time scales of 10-30 s may be particularly important because of the expected increase in the use of implantable defibrillators that typically deliver therapy within this time window. In addition, as evidence from several recent studies indicates, dynamic or time-varying assessment of cycle periods or dominant frequencies during VF may be useful to study the organization of VF in terms of spatio-temporal changes in activation and excitable gap and spatial and temporal variation in cellular properties such as effective refractory periods.
Results of a recent study (18) show that the period of rotation of reentrant activation, mapped with the use of optical measurement of transmembrane voltage, correlates with the dominant frequency within the surface ECG. Results of several studies (21, 22, 30) showed that local cycle periods during VF and AF correlate with effective refractory periods. The changes in frequencies that we estimated can be grouped into those that occur over a short time (of order of 500-1,000 ms) and those that occur over a long time (over 10 s). We observed that over the long time, the dominant frequencies increased or cycle periods decreased, whereas for short time, there was considerable local variation above and below the mean frequencies. We believe, as discussed in detail below, that the long-term changes in frequencies may reflect changes in cellular repolarization properties. Although it is possible that cellular conduction and repolarization properties may change dynamically to affect short-term variation in frequencies also, a more likely cause for the short-term variation may be activation patterns. The symmetrical variation in dominant frequencies above and below the mean, as shown in Figs. 5 and 8, supports the above possibility and also explains the two apparently contradictory observations from previous studies by others: that the effective refractory period correlates with AF and VF cycle length, which would suggest that there is no excitable gap or a constant fixed excitable gap during AF and VF (14, 21, 22), and evidence of an excitable gap (15, 23). Some investigators observed a presence of diastolic potential and thus an excitable gap during VF (7, 23), whereas others observed no diastolic potential during VF (14, 22). Our results suggest that the average (in time) dominant frequency period may correlate (but not necessarily be equal) with the effective refractory period, and short-time changes in frequencies may result because cells within a specific site are stimulated as soon as they are repolarized (no excitable gap present at that site at that time resulting in higher-than-mean dominant frequency, with cycle periods equal to refractory periods; Ref. 16) or are stimulated at intervals longer than their refractory periods (excitable gap present at that site at that time, which would lead to lower-than-mean dominant frequencies). Our results are based on measurements of ECG that are global in a spatial sense; however, the electrical activity recorded at each electrode site can be approximated as the sum of contribution from all myocardial cells, each weighted inversely by the distance of the cell from the electrode. Therefore, changes in frequencies that we observed would be influenced by the integrated effect of activity within a relatively large group of cells.
Results of a study by Mandapati et al. (18) and of previous studies by others (7, 12, 28, 29) have suggested that multiple rotors may coexist within different regions of the heart, and nonstationarity of these rotors may lead to polymorphism in VF. Mandapati et al. (18) discussed the possibility that, because there was a strong correlation between periods of single rotors, mapped within a local region, and dominant frequency within global ECG, multiple spiral waves or rotors will have a narrow range of rotation periods. Our results provide further information regarding this issue. Figure 6 shows that at any time instant, the ECGs recorded from different spatial locations often register different frequencies. Although these data do not provide information regarding existence of multiple rotors or their synchronicity, they do suggest that considerable spatial heterogeneity exists during VF. It is possible that distinct activations within different regions have different rotation periods because of differences in either core size, shape, or conduction velocity. Activations may drift from one region to another or activation pattern within a region may change; these changes would produce temporal variation in the differences in the frequencies between ECGs, i.e., sometimes the frequencies within different ECGs will be similar, and at other times they will be different. Under such conditions, similarity of frequencies between spatially different ECGs, within a given time window, would indicate uniform activation pattern or properties of cellular substrate during that time. We have previously shown that similarity of frequencies within the X and Y ECGs from the 10-s VF trials was correlated with successful defibrillation shock outcome (24). Although we observed short time differences in frequencies between spatially different ECGs, frequencies averaged in time were similar for all three ECGs. The similarity of time-averaged frequencies among the ECGs provides an explanation for the observations of Chorro et al. (8), who reported no differences in frequencies estimated from different electrodes. They (8) used a block of 2.4 s of VF to estimate frequencies, which would be analogous to an averaging in time of our data. To assess whether the frequencies registered within different ECGs were just phase shifted relative to each other, we calculated cross correlations between the dominant frequencies in the X-Y, X-Z, and Y-Z ECG pairs. The cross correlations (which compare 2 signals for similarity at different relative time shifts between them) did not show any consistent peaks, which indicated that the dominant frequencies among the three ECGs were indeed different temporally, not just shifted in time. A delay or time shift in dominant frequencies among ECGs could result from a single, large, nonstationary (in cycle length) activation drifting from one region of the heart to another; our results are not consistent with the existence of such a single large-drifting activation pattern.
Results of trials with amiodarone confirmed that alteration in cellular repolarization (although acute administration of amiodarone has other cellular effects as well; Ref. 9) is reflected in changes in dominant frequencies. We observed that amiodarone decreased dominant frequency, likely a result of prolongation of refractory period. These results are consistent with those of Chorro et al. (9), who also observed a decrease in dominant frequencies after amiodarone. The advantage of using time-frequency analysis was that it permitted us to observe that amiodarone also decreased temporal or short-term variation in dominant frequencies, which could not be observed in earlier studies. This decrease in temporal variation in dominant frequencies may contribute to or reflect the mechanisms that result in anti-arrhythmic qualities of this drug.
We observed that the mean dominant frequencies increased linearly during the first 30 s of VF. It is generally known that during minutes after induction of VF (1 min and longer), the dominant frequencies in ECGs decrease (1, 2, 8, 9, 19). Investigation of dominant frequencies during early VF (<1 min after induction) has also been reported by others (2, 5, 8-10); however, except for the study in humans by Clayton et al. (10) and the study in dogs by Martin et al. (19), in the other studies either an increase was not observed or the observed increase was not statistically significant. The analysis techniques employed earlier included estimation of frequencies from blocks of data, thereby resulting in a loss of the temporal aspect of changes in frequencies. For example, Martin et al. used 13-s blocks of data to estimate frequencies; they observed a significant increase in dominant frequencies in the 26- to 39-s block compared with initial frequencies. Relative to the earlier studies, use of time-frequency analysis permitted us to estimate frequencies with a substantially increased time resolution.
Our results in Fig. 7 show a highly significant and almost linear increase in dominant frequencies during the first 30 s of VF in all three ECGs. Although the exact mechanisms for this increase are unclear, one possibility is that the effective refractory period restitution property of myocardial cells may have contributed to this acceleration. It has been shown previously and in a recent study (4) that, up to a limit, the effective refractory periods decrease as the previous pacing cycle lengths are decreased. It has also been shown by several recent studies (21, 22, 30) that the effective refractory periods in both atrial and ventricular myocardium, estimated with the use of extrastimulus technique, correlate with cycle lengths during AF and VF. It is possible, therefore, that although there may be short time variation in activation intervals, over a longer time, subsequent reentrant activations arrive at specific sites at shorter and shorter intervals on average, the faster activation being facilitated by restitution of effective refractory periods. That is, if the shortening of the refractory periods due to faster activations occurred at a faster rate than the lengthening due to slower activations, then the observed acceleration of VF is possible until a point in time when the slowing effects due to ischemia predominate and cycle periods start to increase. It is also possible, as discussed previously by other investigators (8), that factors such as sympathetic activation, because of loss of blood pressure, may also have contributed to the observed acceleration during VF.
The distribution of frequencies was similar between early and late (first and last 14 s of, respectively) VF. These results suggest that the dominant frequencies were equally likely to be higher or lower than the mean frequency, with similar probability either early or late in VF. After the effects of acceleration due to the hypothesized asymmetrical restitution of refractoriness were factored out, the magnitude of change in frequencies from the mean was similar during the 30 s of VF. The similarity of the distributions in Fig. 8, therefore, suggests that the pattern of activation of VF remains stable during 30 s of VF.
In summary, our results show that during VF 1) frequencies within ECGs change substantially and continuously; 2) during the first 30 s, mean frequencies increase linearly; 3) variability in frequency does not change during 30 s of VF; and 4) at any given time, the frequencies within spatially different body surface ECGs can be markedly different.
There are potential applications for our findings. The results of our study and those of others discussed earlier suggest that time-varying assessment of dominant frequencies during VF from multiple recordings, such as those obtained during body surface, epicardial, or endocardial mapping, may be used to study spatio-temporal variation in conduction and repolarization properties. The time-frequency technique used in our study does not require identification of activation times and may be used to construct cycle-period spatio-temporal maps to study spatio-temporal variation in refractory periods over the entire heart. Such spatio-temporal variation in cellular properties is hypothesized to play an important role in genesis of VF (4).
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported in part by a research grant from The Whitaker Foundation.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: A. R. Patwardhan, Center for Biomedical Engineering and Division of Cardiology, Univ. of Kentucky, Lexington, KY 40506-0070 (E-mail: abhijit{at}pop.uky.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Received 2 August 1999; accepted in final form 3 February 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Baykal, A,
Ranjan R,
and
Thakor NV.
Estimation of the ventricular fibrillation duration by autoregressive modeling.
IEEE Trans Biomed Eng
44:
350-356,
1997.
2.
Baykal, A,
Ranjan R,
and
Thakor NV.
Model-based analysis of the ECG during the early stages of ventricular fibrillation.
J Electrocardiol
27, Suppl:
84-90,
1994.
3.
Bayly, P,
Johnson EE,
Wolf PD,
Greenside HS,
Smith WM,
and
Ideker RE.
A quantitative measurement of spatial order in ventricular fibrillation.
J Cardiovasc Electrophysiol
4:
533-546,
1993[Web of Science][Medline].
4.
Cao, J,
Qu Z,
Kim YH,
Wu TJ,
Garfinkel A,
Weiss JN,
Karaguezian HS,
and
Chen P-S.
Spatio-temporal heterogeneity in the induction of ventricular fibrillation by rapid pacing. Importance of cardiac restitution properties.
Circ Res
84:
1318-1331,
1999
5.
Carlisle, E,
Allen JD,
Bailey A,
Kernohan WG,
Leahey W,
and
Adgey AAJ
Pharmacological analysis of established ventricular fibrillation.
Br J Pharmacol
100:
530-534,
1990[Web of Science][Medline].
6.
Carlisle, E,
Allen JD,
Kernohan AG,
Anderson J,
and
Adgey AAJ
Fourier analysis of ventricular fibrillation of varied aetiology.
Eur Heart J
11:
173-181,
1990
7.
Cha, Y,
Birgersdotter-Green U,
Wolf PL,
Peters BB,
and
Chen P-S.
The mechanism of termination of reentrant activity in ventricular fibrillation.
Circ Res
74:
495-506,
1994
8.
Chorro, F,
Guerrero J,
Canoves J,
Martinez-Sober J,
Mainar L,
Sanchis J,
Calpe J,
Llavador E,
Espi J,
and
Lopez-Marino V.
Quantification of the modifications in the dominant frequency of ventricular fibrillation under conditions of ischemia and repurfusion: an experimental study.
Pace
21:
1716-1723,
1998.
9.
Chorro, F,
Sanchez-Munoz JJ,
Sanchis J,
Cortina J,
Bataller M,
Guerrerro J,
Espi J,
Ruiperez JA,
and
Lopez-Marino V.
Modifications in the evolution of the dominant frequency in ventricular fibrillation induced by amiodarone, diltiazem, and flecainide.
J Electrocardiol
29:
319-326,
1996[Web of Science][Medline].
10.
Clayton, R,
Murray A,
and
Campbell RWF
Changes in the surface electrocardiogram during the onset of spontaneous ventricular fibrillation in man.
Eur Heart J
15:
184-188,
1994
11.
Gray, R,
and
Jalife J.
Mechanisms of cardiac fibrillation.
Science
270:
1222-1223,
1995
12.
Gray, R,
Jalife J,
Panfilov A,
Baxter WT,
Cabo C,
Davidenko JM,
and
Pertsov AM.
Nonstationary vortexlike reentrant activity as a mechanism of polymorphic ventricular tachycardia in the isolated rabbit heart.
Circulation
91:
2454-2469,
1995
13.
Herbschleb J, van der Tweel I, and Meijler FL. The apparent
repetition frequency of ventricular fibrillation. Computers in
Cardiology 249-252, 1982.
14.
Jones, J,
Noe W,
Tovar O,
Lin Y,
and
Hsu W.
Can shocks timed to action potentials in low-gradient regions improve both internal and out-of-hospital defibrillation?
J Electrocardiol
31:
41-44,
1998.
15.
KenKnight, B,
Bayly PV,
Gerstle RJ,
Rollins DL,
Wolf PD,
Smith WM,
and
Ideker RE.
Regional capture of fibrillating ventricular myocardium. Evidence of an excitable gap.
Circ Res
77:
849-855,
1995
16.
Kim, K,
Rodefeld MD,
Shuessler RB,
Cox JL,
and
Boineau JP.
Relationship between local atrial fibrillation interval and refractory period in the isolated canine atrium.
Circulation
94:
2961-2967,
1996
17.
Krattenthaler, W,
and
Hlawatsch F.
Time-frequency design and processing of signals via smoothed Wigner distributions.
IEEE Trans Signal Proc
41:
278-287,
1993.
18.
Mandapati, R,
Asano Y,
Baxter WT,
Gary R,
Davidenko J,
and
Jalife J.
Quantification of effects of global ischemia on dynamics of ventricular fibrillation in isolated rabbit heart.
Circulation
98:
1688-1696,
1998
19.
Martin, G,
Such CM,
Hernandez A,
and
Llamas P.
Relation between power spectrum time course during ventricular fibrillation and electromechanical dissociation. Effects of coronary perfusion and nifedipine.
Eur Heart J
7:
560-569,
1986
20.
McFee, R,
and
Parungao A.
An orthogonal lead system for clinical electrocardiography.
Am Heart J
62:
93-100,
1961.
21.
Misier, A,
Opthof T,
van Hemel NM,
Vermeulen JT,
de Bakker JMT,
Defauw JJAM,
van Capelle FJL,
and
Janse MJ.
Dispersion of refractoriness in noninfarcted myocardium of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarction.
Circulation
91:
2566-2572,
1995
22.
Opthof, T,
Misier ARR,
Coronel R,
Vermuelen JT,
Verberne HJ,
Frank RGJ,
Moulijn ADC,
van Capelle FJL,
and
Janse M.
Dispersion of refractoriness in canine ventricular myocardium. Effects of sympathetic stimulation.
Circ Res
68:
1204-1215,
1991
23.
Pastore, J,
Girouard SD,
Laurita KR,
Akar FG,
and
Rosenbaum DS.
Mechanism linking T-wave alternans to the genesis of cardiac fibrillation.
Circulation
99:
1385-1394,
1999
24.
Patwardhan, AR,
Moghe SA,
Wang K,
Wright H,
and
Leonelli FM.
Time-varying coherence during ventricular fibrillation is correlated with defibrillation shock outcome (Abstract).
Eur Heart J
18:
100,
1997.
25.
Patwardhan, AR,
Moghe SA,
Wang K,
Wright H,
and
Leonelli FM.
Relation between ventricular fibrillation voltage and probability of defibrillation shocks: analysis using Hilbert transforms.
J Electrocardiol
31:
317-325,
1998[Web of Science][Medline].
26.
Patwardhan, AR,
Wang K,
Moghe SA,
and
Leonelli FM.
Bispectral energies within ECG during ventricular fibrillation are correlated with defibrillation shock outcome.
Ann Biomed Eng
27:
171-179,
1999[Web of Science][Medline].
27.
Pola, SA,
Macerata A,
Emdin M,
and
Marchesi C.
Estimation of the power spectral density in non-stationary cardiovascular time series: assessing the role of the time-frequency representations (TFR).
IEEE Trans Biomed Eng
43:
46-59,
1996[Web of Science][Medline].
28.
Starmer, CF,
Romashko DN,
Reddy RS,
Zilberter YI,
Starobin J,
Grant AO,
and
Krinsky VI.
Proarrhytmic response to potassium channel blockade. Numerical studies of polymorphic tachyarrhythmias.
Circulation
92:
595-605,
1995
29.
Uchida, T,
Yashima M,
Gotoh M,
Qu Z,
Garfinkel A,
Weiss JN,
Fishbein MC,
Mandel WJ,
Chen P-S,
and
Karagueuzian S.
Mechanism of acceleration reentry in the ventricle. Effect of ATP sensitive potassium channel opener.
Circulation
99:
704-712,
1999
30.
Wang, L,
Li CY,
Yong AHC,
and
Kilpatrick D.
Fast Fourier transform analysis of ventricular fibrillation intervals to predict ventricular refractoriness and its spatial dispersion.
Pace
21:
2588-2595,
1998.
This article has been cited by other articles:
![]() |
I. Panfilov, N. A. Lever, B. H. Smaill, and P. D. Larsen Ventricular fibrillation frequency from implanted cardioverter defibrillator devices Europace, June 23, 2009; (2009) eup159v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Langley, G.A. MacGowan, and A. Murray Spatial and temporal organization of the dominant frequencies in the fibrillating heart: body surface potential mapping in a rare case of sustained human ventricular fibrillation Europace, March 1, 2009; 11(3): 324 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-R. Choi, W. Nho, T. Liu, and G. Salama Life Span of Ventricular Fibrillation Frequencies Circ. Res., August 23, 2002; 91(4): 339 - 345. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |